Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Risico op nieuwe ziekteactiviteit na stoppen MS-medicatie
aug 2023 | Multipele Sclerose